The Evaluation of In Vitro Effects of Dipyridamole on Coronary Artery Bypass Grafts
Objective: The aim of this study is to evaluate the efficacy of dipyridamole in relieving the vasospasm of coronary artery bypass grafts. Material and Methods: Twenty two patients who underwent elective coronary artery bypass grafting (CABG) were admitted to the study (Men/Women:14/8, mean age: 62.4...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2011-09-01
|
| Series: | Balkan Medical Journal |
| Subjects: | |
| Online Access: | http://tutfd.org/text.php3?id=773 |
| _version_ | 1797907633401757696 |
|---|---|
| author | Turan Ege Okay Güven Karaca Özcan Gür Hakan Karadağ Selami Gürkan Enver Duran |
| author_facet | Turan Ege Okay Güven Karaca Özcan Gür Hakan Karadağ Selami Gürkan Enver Duran |
| author_sort | Turan Ege |
| collection | DOAJ |
| description | Objective: The aim of this study is to evaluate the efficacy of dipyridamole in relieving the vasospasm of coronary artery bypass grafts. Material and Methods: Twenty two patients who underwent elective coronary artery bypass grafting (CABG) were admitted to the study (Men/Women:14/8, mean age: 62.4±8.8 years). Ten samples from left internal mammary(LIMA), radial arterial (RA) and saphenous vein (SV) grafts were collected for each. The samples were transported to the vascular laboratory in 4°C Krebs solution. Submaximal smooth muscle contraction was achieved first by 10-7M of phenylephrine solution. Dipyridamole was then added, starting from a concentration of 10-9M to a concentration of 10-3.5M in two minutes intervals and half logarithmic dose increments. The concentration-response curves were obtained of the vasodilatation response relative to the begining.Results: In the LIMA graft samples, the vasodilation response to dipyridamole was 43.2±1.6% and 97.6±4.1% at concentrations of 10-6M and 10-3.5M respectively. In RA graft samples, the vasodilation response to dipyridamole was 36.3±1.8% and 95.3± 2.7% at concentrations of 10-6M and 10-3.5M respectively. In SV graft samples, however, the vasodilation response to dipyridamole was 43.2±1.4 % and 96.6± 2.2% at concentrations of 10-6M and 10-3.5M respectively.Conclusions: The amplitude of relaxation response to dipyridamole of all grafts samples were similar, without statistically significant difference among the IMA, RA and SV grafts in the in vitro tissue bath system. These results prove that dipyridamole has a potential use as a vasodilatatory drug in all graft types. |
| first_indexed | 2024-04-10T10:39:59Z |
| format | Article |
| id | doaj.art-5809034616b845d6ade02d8d7fc115b5 |
| institution | Directory Open Access Journal |
| issn | 2146-3123 2146-3131 |
| language | English |
| last_indexed | 2024-04-10T10:39:59Z |
| publishDate | 2011-09-01 |
| publisher | Galenos Publishing House |
| record_format | Article |
| series | Balkan Medical Journal |
| spelling | doaj.art-5809034616b845d6ade02d8d7fc115b52023-02-15T16:20:38ZengGalenos Publishing HouseBalkan Medical Journal2146-31232146-31312011-09-012803261263The Evaluation of In Vitro Effects of Dipyridamole on Coronary Artery Bypass GraftsTuran EgeOkay Güven KaracaÖzcan GürHakan KaradağSelami GürkanEnver DuranObjective: The aim of this study is to evaluate the efficacy of dipyridamole in relieving the vasospasm of coronary artery bypass grafts. Material and Methods: Twenty two patients who underwent elective coronary artery bypass grafting (CABG) were admitted to the study (Men/Women:14/8, mean age: 62.4±8.8 years). Ten samples from left internal mammary(LIMA), radial arterial (RA) and saphenous vein (SV) grafts were collected for each. The samples were transported to the vascular laboratory in 4°C Krebs solution. Submaximal smooth muscle contraction was achieved first by 10-7M of phenylephrine solution. Dipyridamole was then added, starting from a concentration of 10-9M to a concentration of 10-3.5M in two minutes intervals and half logarithmic dose increments. The concentration-response curves were obtained of the vasodilatation response relative to the begining.Results: In the LIMA graft samples, the vasodilation response to dipyridamole was 43.2±1.6% and 97.6±4.1% at concentrations of 10-6M and 10-3.5M respectively. In RA graft samples, the vasodilation response to dipyridamole was 36.3±1.8% and 95.3± 2.7% at concentrations of 10-6M and 10-3.5M respectively. In SV graft samples, however, the vasodilation response to dipyridamole was 43.2±1.4 % and 96.6± 2.2% at concentrations of 10-6M and 10-3.5M respectively.Conclusions: The amplitude of relaxation response to dipyridamole of all grafts samples were similar, without statistically significant difference among the IMA, RA and SV grafts in the in vitro tissue bath system. These results prove that dipyridamole has a potential use as a vasodilatatory drug in all graft types.http://tutfd.org/text.php3?id=773Dipyridamolecoronary artery bypass graftleft internal mammarian arteryradial arterysaphenous vein. |
| spellingShingle | Turan Ege Okay Güven Karaca Özcan Gür Hakan Karadağ Selami Gürkan Enver Duran The Evaluation of In Vitro Effects of Dipyridamole on Coronary Artery Bypass Grafts Balkan Medical Journal Dipyridamole coronary artery bypass graft left internal mammarian artery radial artery saphenous vein. |
| title | The Evaluation of In Vitro Effects of Dipyridamole on Coronary Artery Bypass Grafts |
| title_full | The Evaluation of In Vitro Effects of Dipyridamole on Coronary Artery Bypass Grafts |
| title_fullStr | The Evaluation of In Vitro Effects of Dipyridamole on Coronary Artery Bypass Grafts |
| title_full_unstemmed | The Evaluation of In Vitro Effects of Dipyridamole on Coronary Artery Bypass Grafts |
| title_short | The Evaluation of In Vitro Effects of Dipyridamole on Coronary Artery Bypass Grafts |
| title_sort | evaluation of in vitro effects of dipyridamole on coronary artery bypass grafts |
| topic | Dipyridamole coronary artery bypass graft left internal mammarian artery radial artery saphenous vein. |
| url | http://tutfd.org/text.php3?id=773 |
| work_keys_str_mv | AT turanege theevaluationofinvitroeffectsofdipyridamoleoncoronaryarterybypassgrafts AT okayguvenkaraca theevaluationofinvitroeffectsofdipyridamoleoncoronaryarterybypassgrafts AT ozcangur theevaluationofinvitroeffectsofdipyridamoleoncoronaryarterybypassgrafts AT hakankaradag theevaluationofinvitroeffectsofdipyridamoleoncoronaryarterybypassgrafts AT selamigurkan theevaluationofinvitroeffectsofdipyridamoleoncoronaryarterybypassgrafts AT enverduran theevaluationofinvitroeffectsofdipyridamoleoncoronaryarterybypassgrafts AT turanege evaluationofinvitroeffectsofdipyridamoleoncoronaryarterybypassgrafts AT okayguvenkaraca evaluationofinvitroeffectsofdipyridamoleoncoronaryarterybypassgrafts AT ozcangur evaluationofinvitroeffectsofdipyridamoleoncoronaryarterybypassgrafts AT hakankaradag evaluationofinvitroeffectsofdipyridamoleoncoronaryarterybypassgrafts AT selamigurkan evaluationofinvitroeffectsofdipyridamoleoncoronaryarterybypassgrafts AT enverduran evaluationofinvitroeffectsofdipyridamoleoncoronaryarterybypassgrafts |